TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2134265-2009-04532
- Event Type
- Injury
- Date Received
- September 4, 2009
- Date of Event
- March 26, 2008
- Report Date
- August 6, 2009
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- NIQ
- PMA / PMN Number
- P060008
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KS
- Reporter Occupation
- PHYSICIAN
Narratives
IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFO FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. LITERATURE CITATION: VERY LATE THROMBOSIS OF A DRUG-ELUTING STENT AFTER DISCONTINUATION OF A DUAL ANTIPLATELET THERAPY IN PT TREATED WITH BOTH DRUG-ELUTING AND BARE-METAL STENTS. FOREIGN COUNTRY CIRC J 2009; 39: 205-208. KIM SS, JEONG MH, SIM DS, HONG, YJ, KIM JH, AHN YK & KANG, JC.
IT WAS REPORTED IN THE JOURNAL ARTICLE, "VERY LATE THROMBOSIS OF A DRUG-ELUTING STENT AFTER DISCONTINUATION OF A DUAL ANTIPLATELET THERAPY IN PT TREATED WITH BOTH DRUG-ELUTING AND BARE-METAL STENTS," THAT POST PERCUTANEOUS CORONARY INTERVENTIONS (PCI), THROMBOSIS OCCURRED. THE PT PRESENTED WITH MYOCARDIAL INFARCTION (MI) AND ELECTIVE PCI WAS PERFORMED. THE TARGET LESION WAS LOCATED IN THE PROXIMAL RIGHT CORONARY ARTERY (RCA); A 2.75X32MM TAXUS LIBERTE STENT WAS IMPLANTED. POST STENTING PROCEDURE, THE PT WAS ADMINISTERED DUAL ANTIPLATELET THERAPY (ASPIRIN AND CLOPIDOGREL). APPROX TWO YEARS LATER, THE PT RAN OUT OF HIS MEDICATION AND FAILED TO REFILL THE PRESCRIPTION; SIXTEEN DAYS LATER, HE PRESENTED WITH CHEST PAIN. AN ELECTROCARDIOGRAM SHOWED ST-SEGMENT DEPRESSION AND T-WAVE INVERSION IN LEAD II, III AND VF. CORONARY ANGIOGRAPHY REVEALED A TOTAL OCCLUSION OF THE TAXUS STENT DUE TO THROMBUS FORMATION AND GRADE II COLLATERAL FLOW. THE PT UNDERWENT BALLOON ANGIOPLASTY AND THROMBUS ASPIRATION. BLOOD FLOW WAS RESTORED WITHOUT RESIDUAL STENOSIS. NO ADDITIONAL PT COMPLICATIONS WERE REPORTED. AFTER THE PROCEDURE, THE PT WAS PLACED ON ASPIRIN AND CLOPIDOGREL.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM | NIQ STENT, CORONARY, DRUG-ELUTING | NIQ | BOSTON SCIENTIFIC CORPORATION | 2.75X32MM | 8377135 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 49 YR | Required Intervention |